Y Intercept (Hong Kong) LTD Caribou Biosciences, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.78 Billion
- Q2 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 21,989 shares of CRBU stock, worth $42,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,989
Previous 10,385
111.74%
Holding current value
$42,658
Previous $53,000
32.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRBU
# of Institutions
145Shares Held
53.7MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$13.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$8.82 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$8.07 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$7.92 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$5.09 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $118M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...